BIRJU PATEL: Open Payments
NPI 1699018317 · KENILWORTH, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,193 in 67 payments from 14 companies in 2025. Trend: 2023 $1,146 · 2024 $1,842 · 2025 $1,193
Food & beverage: $1,193
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 14 | $267 |
| ABBVIE INC. | 13 | $135 |
| E.R. Squibb & Sons, L.L.C. | 6 | $129 |
| Axsome Therapeutics, Inc. | 4 | $108 |
| Tris Pharma Inc | 5 | $100 |
| Corium, LLC | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Neos Therapeutics, LP | 4 | $72 |
| Lundbeck LLC | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
Products named: Qelbree, VRAYLAR, COBENFY, REXULTI, Dyanavel XR, Azstarys, CAPLYTA, Auvelity.
Industry payments across IL — which companies pay providers there.
